Thursday, July 30, 2009

Doctors Gain New Understanding of Frozen Shoulder Syndrome

Doctors Gain New Understanding of Frozen Shoulder Syndrome

Advances in treatment presented to national audience of health care professionals.

Dallas, TX (PRWEB) July 30, 2009 -- On August 8 and 9, 2009, doctors from across the country will attend the inaugural Frozen Shoulder Syndrome Diagnosis and Treatment™ seminar in Dallas, Texas. The curriculum, developed by OTZ Health Education Systems™ (OTZ™), is based on two years of research and hundreds of successful patient outcomes. Doctors in attendance will receive live training from OTZ founder and curriculum developer Dr. Francis X. Murphy and his distinguished team of OTZ neurologists, chiropractors, and muscle therapy experts.

The OTZ Frozen Shoulder Syndrome Diagnosis and Treatment curriculum will be presented at Parker College of Chiropractic in Dallas. Attendance is limited to licensed health care practitioners seeking clinical competency and certification in the new approach to diagnosing and treating Frozen Shoulder Syndrome, a debilitating ailment affecting millions worldwide. The curriculum and training is accredited for the maximum 12 hours of post-graduate continuing education (CE) credit, and attendees must successfully demonstrate full competency to receive OTZ certification.

In 2007, Dallas chiropractor Dr. Francis X. Murphy put into practice a unique form of analysis and correction targeted at the condition known as Frozen Shoulder Syndrome (FSS). Since then, hundreds of patients with FSS have sought out Dr. Murphy for this treatment and have had their FSS successfully resolved. After two years of observation, study, and the assistance of many health care institutions and patients, a new understanding of the nature and causes of FSS has emerged and has been developed in the OTZ curriculum. FSS has been linked to certain neurological disorders with which the OTZ diagnosis and treatment approach has also shown tremendous promise as well as generated new questions.

The most basic element of the OTZ training is the live demonstration of compelling analysis and treatment on medically diagnosed Frozen Shoulder patients during the seminar. Clinical studies are recorded on digital video and will be made available to enrolled health professionals in early September at http://www.OTZHealthEd.com. The site will offer a Certified OTZ Provider Directory that FSS patients can use to locate a doctor who can effectively treat FSS using the OTZ method. Doctor attendees will also use the site to access the online multimedia Continuing Education Center, where they will have 24/7 access to all OTZ curriculum, including videos, audio podcasts, documents, and new research.

All treatment expenses are being waived for FSS patients who meet the medical requirement and are willing to share the treatment process with doctors attending the OTZ seminar. Sufferers of Frozen Shoulder Syndrome can call (214) 368-3030 to see if they qualify to receive free treatment at an upcoming OTZ seminar. A limited number of cases are treated each month, and treatment requires patients to be in Dallas, Texas for a period of one week.

About OTZ Health Education Systems

OTZ Health Education Systems, LLC (OTZ) is the developer of a proven method of diagnosing and successfully treating Frozen Shoulder Syndrome (FSS). OTZ trains doctors so they can help the millions of people worldwide who suffer from the debilitating effects of FSS. The OTZ method is based on years of research by founder Dr. Francis X. Murphy and encompasses the fields of neurology, chiropractic, and biochemistry to relieve the conditions that cause Frozen Shoulder Syndrome.

CONTACT

Victor A. DiBlasi

OTZ Health Education Systems

214.205.9930

OTZ and OTZ Health Education Systems are trademarks of OTZ Health Education Systems, LLC. All rights reserved.

###



Contact Information Victor DiBlasi

OTZ Health Education Systems, LLC

http://www.otzhealthed.com

214.205.9930



Wednesday, July 29, 2009

NeuroScience Associates Announces Expansion, Increases Capacity to Deliver High Quality Neurohistology Services

NeuroScience Associates Announces Expansion, Increases Capacity to Deliver High Quality Neurohistology Services

NeuroScience Associates, Inc. (NSA) (http://www.nsalabs.com), a global leader in mass-production neurohistology services, announces the opening of a new state-of-the-art facility. NSA projects that the new lab will quadruple its already high throughput capacity for brain and spinal cord histology used in medical and scientific research and development.

Knoxville, TN (PRWEB) July 29, 2009 -- In an effort to meet the growing demands of pharmaceutical companies and research labs, NeuroScience Associates, Inc. (NSA) (http://www.nsalabs.com), a global leader in mass-production neurohistology services, announces the opening of a new state-of-the-art facility. NSA projects that the new lab will quadruple its already high throughput capacity for brain and spinal cord histology used in medical and scientific research and development.

"Today's economic downturn is creating unfortunate bottlenecks and budget constraints for many pharmaceutical and research companies. Many of these organizations, in addition to our longstanding

clients, are outsourcing all or part of their neurohistology needs to us," said Dr. Bob Switzer, founder and president of NSA. "Our new laboratory will enable us to meet these needs and to keep R&D work on pace and below budget for our clients."

By employing NSA's MultiBrain® technology, thousands of sections are stained simultaneously, eliminating the many variables, both human and environmental, that occur under conventional staining protocols. The company's experience in neurohistology has supported key research for solutions to many neurological ailments including Alzheimer's disease, Parkinson's disease, Multiple Sclerosis, Huntington's disease, stroke and neurotoxicity.

Based on recent calculations, MultiBrain® technology, the cornerstone of NSA's high quality and efficient neurohistologic processing, is up to eight times (8X) less expensive than other methods. Mass production neurohistology enables NSA to produce finished slides from the brains and/or spinal cords of hundreds of test animals in as little as three weeks per project. The larger, state-of-the-art laboratory and additional NSA team members will allow NSA to meet the ever-growing needs of clients.

As Dr. Andrew Steele from the California Institute of Technology states in a recent testimonial, "NSA was extremely helpful from my first interactions and throughout the project. NSA's commitment to customer satisfaction is unparalleled, and they are happy to help with the study design and will even find ways to help the customer get their pathology done in the most cost-effective manner. I have worked with several pathologists/clinical labs and am very impressed with the quality of tissue preservation and immunostaining using MultiBrain® technology. The work done by NSA is of the highest quality. I look forward to working with them in the future."

About NeuroScience Associates

A privately held company, founded in 1989, NSA specializes in a unique niche market as providers of high-throughput neurohistology services. Through NSA's proprietary MultiBrain® technology, researchers can significantly reduce their R&D cycle times. Rapid delivery, high quality and low cost of delivery are the results of this technology.

NeuroScience Associates' clients include academic and institutional researchers and all sizes of domestic and international pharmaceutical companies including 15 out of the top 20. For more information, contact Chris Massei @ 866-341-8191, 540-341-8191, or visit http://www.nsalabs.com.

###



Contact Information JODIE POZO OLANO

NeuroScience Associates

http://www.nsalabs.com

540-349-2311



Memory Loss - Prevent and Treat with Lifestyle Changes

Memory Loss - Prevent and Treat with Lifestyle Changes

Just released book, Memory Loss - Prevent and Treat with Lifestyle Changes, helps individuals improve their memory and cut their risk of dementia with lifestyle changes. Also, the book helps families living with dementia get better care for their loved ones. The book is free to download.

Crystal Lake, IL. (PRWEB) July 29, 2009 -- Memory Loss affects millions of people in the United States, and over 5 million suffer from a more severe form for called Dementia, with Alzheimer's dementia being the most common form. Dr. Amarish Dave', a board certified neurologist in private practice in Crystal lake, Illinois, has released a book, titled: Memory Loss- Prevent and Treat with Lifestyle Changes. The book is free to download by clicking here: Memory Loss (http://www.neurologistcare.com/memoryloss.html)

The book reviews the lifestyle changes that can impact memory loss and also reduce one's risk of developing dementia. Dementia is a progressive decline in cognitive functions involving memory, processing of information, and mood changes among others. In addition, the book aims to provide guidance to families of loved ones already diagnosed with dementia. Dr. Dave' states, "Memory loss is an insidious problem for many people. It starts off as a subtle annoyance that many people learn to live with, but left untreated, it can become disabling. And for some, memory loss can be an early sign of dementia."

Many people can significantly reduce their problem with memory loss, and also greatly reduce their risk of developing Alzheimer's dementia, or other forms of dementia, by making lifestyle changes. The book reviews studies that show how lifestyle changes can improve memory and cut your dementia risk. Also, even patients with advance dementia can have improved quality of life and comfort with some non-traditional interventions.

To get a copy of the book for free click here: Memory Loss (http://www.neurologistcare.com/memoryloss.html)

###



Contact Information Dr. Amarish Dave

Neurology Medical Group, Inc.

http://www.neurologistcare.com/memoryloss

815 337 7100

815 477 1555



Monday, July 27, 2009

Atlanta Sleep Medicine Clinic Views Representative Henry Waxman's Denial of Restless Leg Syndrome as a Sign of General Lack of Awareness of the Sleep Disorder

Atlanta Sleep Medicine Clinic Views Representative Henry Waxman's Denial of Restless Leg Syndrome as a Sign of General Lack of Awareness of the Sleep Disorder

Patients and physicians familiar with the symptoms of and treatments for Restless Leg Syndrome respond to Rep. Henry Waxman's denial of the sleep disorder. Waxman's statements also bring to light the overall lack of awareness about the disease among Americans.

Atlanta, GA (PRWEB) July 27, 2009 -- At the beginning of this month, California Rep. Henry Waxman (http://waxman.house.gov/) was released from Cedars-Sinai Medical Center in Los Angeles after treatment from fainting in his office. While on C-SPAN, Waxman was recorded saying that Restless Legs Syndrome is a disease created by pharmaceutical companies to make more money. In a video of this interview (http://www.youtube.com/watch?v=xrwV6viF0-A) that has circulated on YouTube and news sites throughout July, Waxman described his experience arriving at the hospital after fainting:

"Somebody asked me, 'Why is your knee jerking?' And I thought I was making a joke, and I said, 'Well I have Restless Leg Syndrome.' Now, I don't think there is such a thing as restless leg syndrome. I'll probably hear from all those people who have it. But I thought that Restless Leg Syndrome was a disease that was created by a drug company that wanted to sell a drug for the disease they had created. And I was making a joke. Well, when I got out of the hospital, I looked at my record, it said, 'He claims to have Restless Leg Syndrome.' Well, I don't know if there is such a thing or not. I don't have it. But a lot of people start thinking they have medical problems because they've seen too many of these commercials. I don't think that's doing the public a lot of good. It's certainly making the drug companies richer, but it's not doing a lot of good for the public."

Ironically, right after this statement, a caller from Virginia phoned in to deny Rep. Waxman's point. This caller, named Scott, said, "Rep. Waxman, as someone who does have Restless Leg Syndrome (http://www.atlantasleep.com/common-disorders.php) I can tell you that it does exist." After laughter from Waxman, the caller continued, "It's a terrible thing. I had achieved that (RLS) through a back injury."

For those who struggle daily with the disease, Rep. Waxman's statement is anything but humorous. Ms. Elaine Gayle, a woman from Atlanta diagnosed with RLS said, "Restless Leg Syndrome definitely does exist. My sister has it so bad that she sometimes has to stop her car just to walk around and move her legs. When you have RLS, you just can't keep your legs still. At night it's a problem as well. Someone like Rep. Waxman dismissing it is simply a shame."

Russell Rosenberg, Ph.D., the founder and director of The Atlanta Sleep Medicine Clinic (http://www.atlantasleep.com), said, "Some people just don't understand how devastating and real RLS is until they have it themselves. Rep. Waxman's comments are a sign of how people continue to underestimate how great an effect a sleep disorder can have on your well-being."

Dr. Michael Lacey, a board certified sleep doctor (http://www.sleepschool.com/bios.aspx?id=312) who treated Gayle, agrees, "Rep. Waxman's interview is an excellent example of the dismissive nature with which truly disabling sleep disorders have been treated all too often by the uninformed, leading to patients being mislabeled or ignored altogether, rather than receiving appropriate and effective treatment."

Despite, an increase in the availability of sleep services in the United States, there is still a lack of awareness about sleep disorders among the general population. According to the Restless Leg Syndrome Foundation (http://www.rls.org), nearly 10% of the U.S. population may have RLS. Although many in this group have a mild form of this disorder, millions of Americans struggle daily with severe effects of RLS.

In describing her own symptoms, Gayle said, "When you have RLS, you know when you are getting tired because your legs begin to get really uncomfortable. You feel like you have to move your legs around. At night, you often unconsciously move your legs around like you are walking or running. This can be disruptive to not only your own sleeping patterns, but also to your sleeping partner."

Symptoms

So how can you find out if you or someone you know has Restless Legs Syndrome (http://www.rls.org/Page.aspx?pid=543)? The following symptoms are all possible indicators:

•    An irresistible urge to move your legs when resting, sitting, or lying down

•    A strong desire to move your legs that is relieved after walking around

•    Involuntary leg movements while awake or asleep

•    Tiredness or inability to concentrate during the day

•    Difficulty falling or staying asleep at night

Treatment

Although some primary care physicians diagnose and treat RLS, sleep specialists and neurologists often have more specific knowledge and experience with the disorder. At the Atlanta Sleep Medicine Clinic (http://www.atlantasleep.com), Dr. Michael Lacey, a board certified sleep doctor on staff, frequently consults with patients experiencing RLS as well as those with other sleep disorders like sleep apnea, insomnia, and narcolepsy.

Even though a complete cure for RLS has yet to be found, there are FDA-approved drugs on the market that can minimize the symptoms of RLS. There are also lifestyle changes and non-drug treatments that can help (http://www.ninds.nih.gov/disorders/restless_legs/detail_restless_legs.htm). For instance, some vitamin deficiencies can elevate the severity of RLS symptoms. In addition some medications may make RLS worse. Eliminating caffeine and alcohol intake and keeping your diet healthy and balanced may also help minimize the effects of RLS.

About The Atlanta Sleep Medicine Clinic

The Atlanta Sleep Medicine Clinic is a full service diagnostic sleep center that was established in 2008. It was founded by one of the early pioneers in sleep medicine, Russell Rosenberg, Ph. D, D.ABSM, and his longtime associate, Michael Lacey, MD, D.ABSM. The Atlanta Sleep Clinic is Georgia's first clinic to be affiliated with the well-known Sleep School, The Atlanta School of Sleep Medicine and Technology. For more information about The Atlanta Sleep Clinic, please visit the clinic's web site at www.atlantasleep.com. Media Contact: Laura Baareman, The Atlanta Sleep Medicine Clinic, (770)883-6679.

# # #



Contact Information Laura Baareman

The Atlanta Sleep Medicine Clinic

http://www.atlantasleep.com

770-883-6679



Wednesday, July 22, 2009

Two Years Remain for Physicians to Obtain Sleep Medicine Certification without Fellowship Training

Two Years Remain for Physicians to Obtain Sleep Medicine Certification without Fellowship Training

Two years remain for physicians to bypass a year of area-specific training in their pursuit of Sleep Medicine Certification. The Atlanta School of Sleep Medicine and Technology will offer a board review course for Sleep Board Certification from October 3-5, 2009, that stresses the knowledge that is essential for success on the exam.

Atlanta, GA (PRWEB) July 22, 2009 -- Physicians interested in becoming board certified in the growing field of sleep medicine have two years remaining to take advantage of a 5-year "Grandfathering" period where they can potentially bypass a one-year sleep medicine fellowship that will be required of all candidates starting in 2012. Only two more board exams (http://www.aasmnet.org/ABMS.aspx) remain in this 5-year period, one in November 2009 and one in Fall 2011.

Following a decision made by several key medical boards in 2006, one path towards taking the sleep board exam has been significantly shortened. Physicians who are board certified in psychiatry, internal medicine, neurology, pediatrics, ENT, or Family Medicine and who meet the requirements of the practice pathway (http://www.abpn.com/sleep.htm) have the opportunity to sit for the exam without a one year sleep medicine fellowship.

For physicians who are taking advantage of this period, The Atlanta School of Sleep Medicine and Technology (http://www.sleepschool.com) has developed a unique course offering developed specifically to prepare them for the national sleep board exam to be held on November 19, 2009.

The school's 3-day weekend review course (http://www.sleepschool.com/page.aspx?id=156) gives physicians a boost in their preparations for the challenging day-long exam in November by reviewing a variety of clinical sleep disorders and sleep sciences as well as other skills tested on the board exam. The instructors mix lectures with case-based presentations and technology to create a unique study experience that gives doctors a solid foundation for preparing the rest of the month. Michael Rinow, MD, who passed the boards in 2007, said, "The Atlanta School's lectures feature sleep experts (http://www.sleepschool.com/bios.aspx) who are nationally known. The board review course places a great emphasis on mastering clinical parameters of various sleep problems and knowing the International Classification of Sleep Disorders."

Ramamurthy Bangalore, MD, who also used the review course to prepare for the boards said he appreciated the Atlanta School for its smaller class size. "The small group made the course more focused on the individual. At courses with too many people you feel disconnected. At the Atlanta School you feel like someone is tutoring you."

Dr. Bangalore, decided to get board certified after realizing how essential sleep is to the overall health of his patients. "In the past, doctors rarely even asked about their patient's sleep quality, which adds up to one-third of their life! Since studying sleep medicine I am better able to teach patients and help them with their sleep problems."

Edward Sall, MD, who took the Atlanta School's Early Bird Review Course in the spring, said that as a dentist and an ENT, the field of sleep medicine is all around him. "The sleep medicine field is a natural extension of what I already do. There is growing awareness about the importance of sleep and an aging population that both contribute to sleep medicine's growth. The momentum in the field right now combined with sleep's increasing role at my practice has given me a desire to get board certified in sleep medicine."

The review course features the school's founder and director (http://www.sleepschool.com/bios.aspx?id=304), Russell Rosenberg, Ph. D., ABSM, as one of the lead instructors. Dr. Rosenberg is an experienced board certified sleep specialist and educator. He lectures and teaches internationally on a range of sleep medicine topics. Dr. Rosenberg's expertise includes insomnia and disorders of excessive daytime sleepiness.

In addition to the 3-day board review course, the Atlanta School offers an optional one-day Digital Records Review Course (http://www.sleepschool.com/page.aspx?id=156) with Terrence Malloy, RPSGT. This precursor to the main course gives physicians an extra day to look at records and hone this skill that will be tested on the November exam.

About The Atlanta School of Sleep Medicine

Since 1992, the Atlanta School of Sleep Medicine & Technology in Atlanta has offered introductory and review courses for more than 5,000 physicians and health care professionals in sleep medicine and polysomnography. Four-day intensive introductory courses are designed for physicians and 80-hour courses, which include an online component, are designed for sleep technologists and allied health care professionals. The Atlanta School also offers special topics including Sleep Medicine for Nurse Practitioners and Physician Assistants, Sleep Medicine for Industry Professionals, and has an Online Learning Center that features a technologist registry preparatory course. For more information about the Atlanta School of Sleep Medicine, please visit the school's web site at www.sleepschool.com. Media Contact: Laura Baareman, The Atlanta School of Sleep Medicine and Technology, (770)883-6679.

###



Contact Information Laura Baareman

The Atlanta School of Sleep Medicine and Technology

http://www.sleepschool.com

770-883-6679



Tuesday, July 21, 2009

Clarian Health/Indiana University School of Medicine Specialty Programs Ranked Among Best in Nation

Clarian Health/Indiana University School of Medicine Specialty Programs Ranked Among Best in Nation

Clarian/IUSM programs are the only Indiana programs included in prestigious national rankings

Indianapolis, IN (Vocus) July 21, 2009 -- Nine clinical programs at Clarian Health (www.clarian.org)/Indiana University School of Medicine (http://www.medicine.iu.edu/) are ranked among the top 50 national programs in U.S. News & World Report's "2009-10 America's Best Hospitals" guide. Clarian's Methodist Hospital and Indiana University Hospital are the only Indiana hospitals included in the rankings, and are among only 174 hospitals recognized out of the 4,861 evaluated nationwide.

Published in the July 21 issue of U.S. News & World Report, the guide ranks clinical programs at Clarian, a partner of Indiana University School of Medicine, in nine of the 16 specialties evaluated. This is U.S. News' 20th year of ranking America's elite medical centers "to help patients find the best hospital when the need is great"; it is Clarian/IUSM's 12th consecutive appearance in the guide.

In June, seven specialty programs at Riley Hospital for Children were ranked among the top 30 children's hospitals in the nation. Riley's urology program was ranked third in the nation.

The complete guide and hospitals rankings are available online at www.usnews.com.

Clarian's recognized adult programs and their numerical rankings are:

* Gastrointestinal Disorders 13th

* Urology 16th

* Orthopedics 24th

* Neurology & Neurosurgery 26th

* Ear, Nose, Throat 26th

* Respiratory Disorders 26th

* Geriatric Care 27th

* Cancer 32nd

* Kidney Disease 38th

Riley Hospital for Children recognized programs and their numerical rankings are:

* Urology 3rd

* Diabetes & Endocrine Disorders 12th

* Neonatal Care 14th

* Respiratory Disorders 14th

* Digestive Disorders 18th

* Neurology & Neurosurgery 27th

* Orthopedics 28th

"We are honored to be listed alongside the top hospitals in the country," said Daniel F. Evans, Jr., president and CEO of Clarian Health (www.clarian.org). "This is our second recognition this year, as Riley Hospital for Children was recognized among the nation's top pediatric hospitals. I'm extremely proud of the hard work by all our staff and physicians at Clarian and the IU School of Medicine to improve the health of our patients and our community. It's their daily dedication that moves us toward a preeminent health care system."

"These rankings once again demonstrate the dedication to quality care and service by the Clarian Health and School of Medicine physicians and faculty, caregivers and staff. I commend all those who make this partnership a successful contributor to the health of Hoosiers and to our life sciences initiative," said D. Craig Brater, M.D., dean of the Indiana University School of Medicine (www.medicine.iu.edu) and IU vice president for life sciences.

CONTACT:

Clarian Health

James Wide

317.962.4589

# # #



Contact Information James Wide

Clarian Health

http://www.clarian.org

317-962-4589



Brunswick Labs Certifies Antioxidant Power of Vindure 900 from Vinomis Laboratories

Brunswick Labs Certifies Antioxidant Power of Vindure 900 from Vinomis Laboratories

Brunswick Laboratories, the leader in antioxidant testing of foods and supplements, has determined that each Vindure 900 tablet from Vinomis Laboratories has an ORAC rating of 19,638, over six times times the USDA recommended daily consumption of at least 3000 ORAC units.

Pittsburgh, PA (PRWEB) July 21, 2009 -- Brunswick Laboratories, the leader in antioxidant testing of foods and supplements, has determined that each Vindure 900 tablet from Vinomis Laboratories has an ORAC rating of 19,638, over six times times the USDA recommended daily consumption of at least 3000 ORAC units. A copy of the Brunswick report (http://www.vinomis.com/images/Brunswick.pdf) is posted on the Vinomis website (http://www.vinomis.com).

Antioxidants (http://www.vinomis.com/antioxidants.do) are chemicals which "scavenge" free oxygen radicals from the body, preventing cell damage from oxidation. Health problems such as heart disease, macular degeneration, strokes, Alzheimer's, diabetes, cancer etc. are all contributed to by oxidative damage from free radicals. According to Dr. Bryan Donohue, chief of cardiology at UPMC, "Our bodies produce free oxygen radicals as a natural by-product of energy production in cells. However, as we age, the mechanisms for neutralizing them decrease. The excess free radicals cause cellular damage, and by reacting with cholesterol in the bloodstream, form deposits that can clog arteries."

According to Jeff Bost PAC, author of "Fish Oils - The Natural Anti-Inflammatory," and Clinical Instructor in Neurological Surgery at UPMC, "the increasing level of environmental toxins, and a long-term decline in the antioxidants found in our foods, make antioxidant supplements a vital component of good health."

Dr. Mehmet Oz, on the "Oprah" website, demonstrates antioxidant power by comparing apples to apples--one half of an apple is sprinkled with lemon juice and the other is not. While the lemony half remains new and crisp-looking, the untreated half becomes brown and shriveled because of exposure to oxygen, also called oxidation. "The same thing happens to our skin, to our heart, to our eyes," Dr. Oz says. "All of our bodies need to have the antioxidants."

The antioxidant power of Vindure comes from a hefty dose of its three primary ingredients: over 400mg of 98% pure trans-Resveratrol, 100mg of pure Quercetin, and 400mg of red wine grape extract containing over 90% polyphenols. According to Mark Juliano, Vinomis CEO, "The Resveratrol, Quercetin, and other Polyphenols in Vindure provide a double benefit - they are super-powerful antioxidants, as well as SIRT gene activators."

In 2003, a team of scientists at Harvard Medical School discovered that 19 polyphenols, of which 17 are found in red wine grapes, activate the SIRT genes, causing them to produce enzymes call Sirtuins that are a critical component in slowing down the aging process. Resveratrol was found to be the number one activator of these genes. Every 100mg of pure Resveratrol has the added benefit of adding over 3000 ORAC units of antioxidants, to our diet.

Antioxidants have received a lot of attention from promoters of "super-fruit" products, containing Acai, Blueberry, Mangosteen, Noni, and Pomegranate. But it turns out that each Vindure tablet, containing over 860mg of pure polyphenols including 400mg of whole Bordeaux grape extract, exceeds the antioxidant power found in an average serving of ANY of the so-called "superfruits."

The relationship between antioxidants and various health issues has been well established. According to the National Cancer Institute, "Considerable laboratory evidence from chemical, cell culture, and animal studies indicates that antioxidants may slow or possibly prevent the development of cancer." The American Academy of Family Physicians recommends supplementation with antioxidants (except beta carotene) to prevent coronary heart disease, reporting that, "… studies find lower coronary heart disease morbidity and mortality in persons who consume larger quantities of antioxidants in foods or supplements."

Vinomis Laboratories develops and distributes nutraceutical products based upon new science from an exclusive Harvard Medical School license. Their products are formulated to provide the benefits of red wine polyphenols, including Resveratrol and Quercetin, in the highest quality products.

###



Contact Information Barry Yarkoni

Vinomis Laboratories

http://www.Vinomis.com

323-282-7224



Thursday, July 16, 2009

Meningitis in Dogs Treatable with Early Detection of Meningitis Symptoms

Meningitis in Dogs Treatable with Early Detection of Meningitis Symptoms

Veterinary neurologist commends efforts to increase awareness of meningitis symptoms and meningitis treatment by New Jersey legislature. Pet owners also should be aware that knowing the symptoms of meningitis and getting early meningitis treatment can mean a full recovery for many dogs.

SARASOTA, FL (PRWEB) July 16, 2009 -- As the New Jersey Senate considers designating August as Meningitis Awareness Month, veterinary neurologist, Dr. Anne Chauvet, is encouraging dog owners to increase their awareness of canine meningitis for their dogs' health (http://petneuro.com/neurologist).

Although some forms of meningitis can be fatal, in most dogs it can be treated successfully if the disease is caught early and the dog receives proper veterinary care, which is why awareness of the disease, its symptoms and treatment is important, said Dr. Anne Chauvet, founder of Veterinary Neuro Services.

    

"I commend the New Jersey Senate Health, Human Services and Senior Citizens Committee for approving legislation that would help raise awareness of this disease in humans," Chauvet said, "and I hope that pet owners will become as aware of the symptoms and the importance of early treatment for their dogs." The bill, SJR-65, to designate August as Meningitis Awareness Month, was introduced by Senator Sean T. Kean, R-11.

Meningitis, which is an inflammation of the membrane (meninges) that wraps the brain and spinal cord, may be caused in dogs by tick-borne diseases such as Lyme, Rocky Mountain spotted fever and ehrlichiosis or parasitic diseases like toxoplasmosis. A common cause of meningitis in dogs is a central nervous system disease known as granulomatous meningoencephalomyelitis (GME,) and toy or small breeds may be susceptible to meningitis caused by immune dysfunction, Chauvet said.

    

Sterile (or idiopathic) meningitis is the most common form of canine meningitis, and usually occurs in young dogs a year old or less. Sterile meningitis symptoms (http://petneuro.com/neurovideo) typically are neck pain along with a fever that waxes and wanes. Other symptoms of meningitis can include changes in gait where the dog looks as though he is walking on eggshells, she said. Affected dogs may have a lot of pain everywhere except their joints, which is one way to distinguish sterile meningitis from polyarthritis and other conditions that exhibit painful joints. Neurological symptoms, such as seizures or blindness, usually are not present unless the disease is advanced.

    

A meningitis diagnosis (http://www.petneuro.com/services) can be confirmed with a spinal tap when the spinal fluid shows a very high number of white blood cells and high levels of protein. An MRI also is an important diagnostic tool that can rule out a disc herniation, infection or other problem that could cause the symptoms, Chauvet said.

    

Sterile meningitis is treated with high doses of steroids, such as prednisone, to suppress the immune system supported with doxycyline, an antibiotic. Sometimes more advanced treatments or combination therapies are required, such as immunoglobulin therapy or chemotherapy drugs, depending on the patient's need. In most cases, the dog responds quickly and is back to normal in a few days, Chauvet said, but treatment must be extended over weeks and sometimes months with most dogs recovering fully.

About Veterinary Neuro Services:

Dr. Anne Chauvet, one of about 150 veterinary neurologists and neurosurgeons in North America, is the founder of Veterinary Neuro Services in Sarasota, Fla. Veterinary Neuro Services treats brain, spinal cord and neuromuscular conditions in animals and is the only strictly neurology and neurosurgery practice on Florida's Gulf Coast.

More information is available by calling 941-929-1818 or online at www.PetNeuro.com.

###



Contact Information Sue Engelhart

Veterinary Neuro Services

http://www.PetNeuro.com

941-926-4245



Wednesday, July 15, 2009

Alzheimer's and Dementia: What's the Truth? And What's a Myth?

Alzheimer's and Dementia: What's the Truth? And What's a Myth?

Because the Truth Can Be Misleading, Gilbert Guide, Most Comprehensive Site on the Web for Aging & Senior Care Adds Alzheimer's Expert to Help Educate Americans.

San Francisco, CA (PRWEB) July 15, 2009 -- By 2050, 16 million people will have Alzheimer's disease in America, according to a recent study by the Alzheimer's Association. Yet many questions linger unanswered about prevention and detection along with what is truth or myth about a condition that may affect one of our loved ones.

Gilbert Guide, the most comprehensive site on the web for aging and senior care, has just introduced Alzheimer's and Dementia expert Dennis Fortier to their ever-growing pool of Aging Guide experts on Gilbert Guide. Mr. Fortier is the President and CEO of Medical Care Corporation, a neuro-informatics company that develops assessment technologies to enable physicians to objectively evaluate memory and other cognitive functions in their patients. His column will bring to light the truths and myths behind mild cognitive impairment, Alzheimer's disease or other forms of dementia while also discussing the benefits of early identification and timely intervention against medical conditions that impair brain function.

"We have nearly 25 topic-specific experts about issues and health conditions related to the aging process," said Jill Gilbert, CEO of Gilbert Guide. "We're excited to be bringing Dennis Fortier on board who can help demystify the disease for the five million Americans that Alzheimer's affects today. Whether it is understanding what kinds of things can improve the condition, myths around the memory loss process, or what can help families dealing with a family member who has Alzheimer's disease, we want to better inform the public about their options."

Gilbert Guide provides families with not only the most comprehensive senior care directory on the web for aging parents and loved ones, but also a direct line to practical solutions, extensive expert advice and quality assessment tools that help them conduct their own "expert" evaluations of providers.

The site is unbiased and not linked to or paid by any organization, product or service. As Jill Gilbert points out, "With everything under one roof, our goal is to make it simple and pain-free for American families to learn about all the issues that relate to aging and senior care, whether that be a health condition like Alzheimer's, aging in place or insurance for seniors."

Other Gilbert Guide Expert topics people can read about and learn from include:

- Senior Moving Solutions

- Financing Long-Term Care

- Hospice

- Adult Incontinence

- Senior Health

- Geriatric Pharmacology

- Naturopathic Medicine

- Senior Nutrition

- Real Estate for Seniors

- Financial Planning for Retirement

- Supportive Homecare

- Funeral Planning

- Articles on Life Coaching

- Geriatric Care Management

- Geriatric Care Solutions

- Acupuncture

- Legal Advice for Seniors

- Aging in Place Technology

- Mind-Body Medicine

- Family Law & Mediation

- Caregiving: Parenting Your Parents

and

- Jill Gilbert's very own column about what she's learned titled Simplifying Senior Care: One Lesson at a Time

About Gilbert Guide

Established in 2004, Gilbert Guide is the leading senior care website where families find practical solutions, expert information and the most comprehensive senior housing guide and homecare directory for aging parents and loved ones. It was founded on the concept that quality matters, and its primary goal is to educate consumers on a breadth of senior care and aging issues. For more information: www.gilbertguide.com.

Media Contact:

Renee Blodgett or Erica Zeidenberg

Blodgett Communications

renee at blodgettcomm dot com

erica at blodgettcomm dot com

925.631.0553

###



Contact Information Jill Gilbert

GilbertGuide

http://www.gilbertguide.com

925-631-0553



Tuesday, July 14, 2009

Coping With Tragedy, Family Takes Action After Mom, Brother, Aunt Suffer Strokes: Lecture Series Welcomes Gorelik to Support Stroke Research and Screening at University of Iowa

Coping With Tragedy, Family Takes Action After Mom, Brother, Aunt Suffer Strokes: Lecture Series Welcomes Gorelik to Support Stroke Research and Screening at University of Iowa

When tragedy struck the Stoppelmoor family, it didn't discriminate based on age or gender. It started with the middle-aged mother, Shirley, who suffered a massive stroke and died at 56. Next, it was her son, Steve, who succumbed to a massive stroke at 37 -- but lived. The final victim was Shirley's sister, Donna, who also survived but with visible reminders that are still with her today. Thanks to Shirley's husband, Wayne Sr., The Shirley A. Stoppelmoor Stroke Research Fund was created to honor the memory of Shirley as a way to build community awareness and understanding about stroke, its symptoms, treatment, and prevention. This week, the Stoppelmoor Lecture Series will welcome Dr. Philip Gorelik in support of stroke research and screening at the University of Iowa on Friday, July 17th.

Iowa City, IA (PRWEB) July 14, 2009 -- The Stoppelmoor family story is one of tragedy and triumph. It is also a story that its family members want to share publicly with as many people as they can. To that end, on Friday, July 17th, the Stoppelmoor Lecture Series will welcome Dr. Philip Gorelik to campus in support of stroke research and screening at the University of Iowa. The lecture is part of an ongoing educational series sponsored by the Shirley A. Stoppelmoor Stroke Research Fund, created to build community awareness and understanding about stroke, its symptoms, treatment, and prevention.

By way of background, the Stoppelmoor family had it all…a loving, nurturing, and highly capable mother; a bright, successful, well-respected father; five smart, athletic, popular children; and Aunts, Uncles, and Cousins whom they all adored. Then, with little warning, tragedy struck. First, Shirley Stoppelmoor, the youthful, energetic, matriarch of the family, suffered a massive stroke and died at the age of 56. Then, one of her sons, Steve, a young husband and father himself, succumbed to a massive stroke at the age of 37 -- but with the help of his wife, knew the warning signs and took the immediate actions step needed to seek proper medical attention. If that wasn't tragedy enough for one family, Shirley's sister, Donna, suffered yet another stroke - but like her Nephew, was fortunate enough to be with a family member to take quick action to ensure proper treatment was administered within the critical minutes following the stroke.

Shirley wasn't as lucky as her Son and Sister. Even though she sought medical attention to help identify the cause of her nagging fatigue during the weeks leading up to her stroke, it wasn't enough to prevent the devastating event that ended her life far too early and abruptly. Steve was more fortunate. Today, he exhibits no visible signs of having suffered a stroke. Instead, he lives a normal life, but one in which he can't help but wonder if it will happen again. Shirley's sister didn't fare quite as well as her nephew. Today, she bares some visible reminders of her stroke that are likely to stay with her for the rest of her life.

For a family that has endured the tragedy and wrath of stroke not once, but three times, there was little choice but to take quick action designed to honor Shirley's memory and establish a much-needed initiative to build community awareness and understanding about stroke, its symptoms, treatment, and prevention. With generous support from Shirley's husband, Wayne Sr., the Stoppelmoor Stroke Research Fund was established in the Department of Neurology at the University of Iowa's College of Medicine.

Thanks to the efforts of Dr. Harold Adams, a renowned neurologist dedicated to stroke prevention, treatment, and research at the University of Iowa's College of Medicine, there have been several visiting lectures addressing a host of stroke-related topics by renowned medical experts. This Friday's lecture by Dr. Philip Gorelick, Professor and Head of Neurology and Rehabilitation, Director, Stroke Research at the University of Illinois in Chicago, is no exception. Titled Vascular Cognitive Impairment: New Insights, the lecture will be held from 11:00 a.m.-12:00 p.m. CST at the Damasio Conference Center. Following the lecture, participants will better understand the diagnosis and treatment of neurological diseases.

According to Wayne Stoppelmoor, Sr., "The debilitating effects from stroke can be minimized if victims and their family members understand the warning signs and symptoms of stroke, as well as the need to seek urgent medical attention within the critical period immediately following the stroke." Stoppelmoor added, "If nothing else, we hope the Shirley A. Stoppelmoor Stroke Research Fund is able to educate individuals and families like ours about stroke prevention and treatment, so they're able to lead full and productive lives beyond their period of recovery."

About The Stoppelmoor Stroke Research Fund

With stroke being the leading cause of disability in the United States, the mission of the Stoppelmoor Stroke Research Fund is to save lives and minimize disability through prevention and research. Housed within the Department of Neurology at the University of Iowa's Carver College of Medicine, the Stoppelmoor Stroke Research Fund is dedicated to expanding the medical community understanding of stroke, particularly among children and young adults. Through two major initiatives, one focused on the design of clinical trials to test treatments for stroke in children, and the other to develop a much-needed visiting lecture series, significant strides are being made to address the Fund's mission-focused work. To learn more about the Shirley A. Stoppelmoor Stroke Research Fund and / or to find out how you can help support its efforts, please visit Shirley's Hope at www.poststrokehope.blogspot.com or the University of Iowa Foundation at http://www.uifoundation.org/waysToGive.shtml.

###



Contact Information Michael Oxman

Shirley A. Stoppelmoor Stroke Research Fund

http://www.poststrokehope.blogspot.com

847-226-4158

Kate Carinder

Dept. of Neurology at the Univ. of Iowa College of Medicine

http://www.uifoundation.org/waysToGive.shtml

319-330-3996



Sunday, July 12, 2009

Long Island Neuroscience Specialists Welcomed As Faculty Appointments in The Department Of Neurosurgery At Weill Cornell Medical College

Long Island Neuroscience Specialists Welcomed As Faculty Appointments in The Department Of Neurosurgery At Weill Cornell Medical College

Patchogue based Long Island Neuroscience Specialists, the office of Dr. Sumeer Sathi, Dr. Steven P. Leon and Dr. Meeru Sathi-Welsch have recently become the only neurosurgery practice in Nassau and Suffolk counties to have faculty appointments with Weill Cornell Medical College.

Patchogue, NY (PRWEB) July 12, 2009 -- Led by Dr. Sumeer Sathi, Long Island Neuroscience Specialists (LINS) have been confirmed as faculty by the Department of Neurosurgery at Weill Cornell Medical College.

The collaboration, which is the first of its kind to be bestowed upon a neurosurgery practice in Nassau and Suffolk counties, will facilitate treatment by Weill Cornell for patients of LINS. "I think that it will provide a gateway for patients in our community to a very high quality tertiary care neurosurgical facility. We're very proud to be part of a world-class facility which was ranked number one in New York State, and number four in the United States, for neurology and neurosurgery WWD in US News & World Report," said Dr. Sathi.

Dr. Sumeer Sathi, Dr. Steven P. Leon and Dr. Meeru Sathi-Welsch are now considered Weill Cornell faculty, and will be representatives for the institution at Long Island Neurosurgery Specialists. Their patients will be receiving the same level of world class care that would be expected at Weill Cornell.

Dr. Philip E. Stieg, Ph. D., M.D., Chairman of the Department of Neurological Surgery at Weill Cornell Medical College, and Neurosurgeon-in-Chief at NewYork-Presbyterian Hospital/Weill Cornell, is pleased to welcome Long Island Neuroscience Specialists to Weill Cornell Medical College. "We look forward to a continued partnership with Dr. Sathi and the staff at Long Island Neuroscience Specialists as we seek to expand our clinical activities to benefit patients in the areas of neurological and spinal treatment and surgery." For additional information regarding Long Island Neuroscience Specialists, please contact LINS.

Contact:

100 Hospital Rd Long Island Neuroscience Specialists Suite 216 Patchogue, NY 11772

Ron Gold, President

Marketing Works

631 444 0176

###



Contact Information Ron Gold

Long Island Neuro

http://longislandneuro.com/

631 444 0176



Thursday, July 9, 2009

Link Between Migraines and Reduced Breast Cancer Risk Confirmed in Follow-Up Study

Link Between Migraines and Reduced Breast Cancer Risk Confirmed in Follow-Up Study

Migraines associated with reduced breast cancer risk. Risk did not differ based on a woman’s age. Migraine triggers irrelevant.

Philadelphia, PA (Vocus) July 9, 2009 -- The relationship between migraine headaches in women and a significant reduction in breast cancer risk has been confirmed in a follow-up study to landmark research published last year. Results of this new study showed a 26 percent reduced risk of breast cancer among premenopausal and postmenopausal women with a clinical diagnosis of migraines.

The study appears in the July issue of Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. Christopher I. Li, M.D., Ph.D., led the first-of-its-kind study linking migraines with breast cancer risk reduction, which was published in the same journal last November. Li is a breast-cancer epidemiologist and associate member of the Fred Hutchinson Cancer Research Center’s Public Health Sciences Division, in Seattle.

This time, Li and colleagues found that the risk reduction remained statistically similar regardless of a woman’s menopausal status, her age at migraine diagnosis, use of prescription migraine medications or whether she avoided known migraine “triggers” such as alcohol consumption, smoking and taking hormone replacement. These triggers are also well-established breast cancer risk factors.

Some key differences between this study and the initial one in which Li and colleagues discovered the link include:

•    The sample size was more than four times larger this time – more than 4,500 cases and controls versus about 1,000 each in the first study – and was more diverse geographically, drawing women from five metropolitan areas instead of only one. “From an epidemiological perspective, having a larger and more diverse study in its underlying population helps in replicating the finding,” said Li.

•    The age range of women studied was wider this time, 34 to 64 years of age versus 55 to 74 years of age. “We were able to look at whether this association was seen among both premenopausal and postmenopausal women,” he said. “In breast cancer this is relevant because there are certain risk factors that are different between older and younger women. We saw the same reduction in breast cancer risk associated with a migraine history regardless of age.”

•    Researchers were able to ascertain whether women in the study had lifestyle behaviors that are known migraine triggers – alcohol consumption, smoking and taking hormone replacement therapy. They posited that perhaps women who had migraines drank and smoked less and didn’t take hormone replacements. “In this study we looked at women who never drank, never smoked and who also didn’t use hormones and found the same association within each of those groups, suggesting that the association between migraine and reduced breast cancer risk may be independent of those other factors and may stand alone as a protective factor,” said Li.

What remains unknown is why migraines are associated with lower breast cancer risk.

“We know that migraines are definitely related to hormones and that’s why we started looking at this in the first place,” said Li. “We have different ideas about what may be going on but it’s unclear exactly what the biological mechanisms are.”

In the meantime, research on migraines and breast cancer continues. Li and colleagues are conducting a follow-up investigation among the women in the first study to determine the types, timing, intensity and severity of their migraines in hopes that the data may elicit additional clues.

Joanne F. Dorgan, Ph.D., M.P.H., an epidemiologist at Fox Chase Cancer Center in Philadelphia, said that non-steroidal anti-inflammatory drugs are frequently used to treat migraine and these drugs have been associated with lower breast cancer risk in some studies. Additional research is needed to clarify the effect of non-steroidal anti-inflammatory drugs use on the observed association between migraines and breast cancer.

“Estrogen and progesterone are neurosteroids, and investigations into neuroendocrine pathways in relationship to breast cancer risk might also prove to be fruitful,” said Dorgan, who is also an editorial board member of Cancer Epidemiology, Biomarkers & Prevention.

Subscribe to the Cancer Epidemiology, Biomarkers & Prevention (http://cebp.aacrjournals.org/rss/recent.xml)

RSS feed.

The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, AACR is the world’s oldest and largest professional organization dedicated to advancing cancer research. The membership includes more than 28,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and nearly 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants. The AACR Annual Meeting attracts more than 17,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. The AACR publishes six major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; and Cancer Prevention Research. The AACR also publishes CR, a magazine for cancer survivors and their families, patient advocates, physicians and scientists. CR provides a forum for sharing essential, evidence-based information and perspectives on progress in cancer research, survivorship and advocacy.

###



Contact Information Tara Yates

American Association for Cancer Reearch

http://www.aacr.org

267-646-0558



Tuesday, July 7, 2009

Revolutionary New Sleep Medicine Course Allows Nurse Practitioners and Physician Assistants to Treat Sleep Medicine Patients

Revolutionary New Sleep Medicine Course Allows Nurse Practitioners and Physician Assistants to Treat Sleep Medicine Patients

The Atlanta School of Sleep Medicine announced today its new sleep medicine course designed specifically for Nurse Practitioners and Physician Assistants. This course is the first of its kind and will provide Nurse Practitioners and Physicians Assistants with the knowledge they need to recognize and diagnose sleep disorders. The class runs from October 24-25, 2009 and will offer continuing education credits.

Atlanta, GA (PRWEB) July 7, 2009 -- The Atlanta School of Sleep Medicine (http://www.sleepschool.com) announced today its new sleep medicine course (http://www.sleepschool.com/page.aspx?id=744) designed specifically for Nurse Practitioners and Physician Assistants. This course is the first of its kind and will provide Nurse Practitioners and Physicians Assistants with the knowledge they need to recognize and diagnose sleep disorders. The class runs from October 24-25, 2009 and will offer continuing education credits.

Dr. Michael Lacey (http://www.sleepschool.com/bios.aspx?id=312), a board certified sleep doctor and instructor at the school, decided to develop the curriculum after realizing that Nurse Practitioners and Physicians Assistants are increasingly important components of physician's practices.

According to recent estimates from the American Academy of Nurse Practitioners, the number of nurse practitioners in the United States has increased by nearly 40 percent during the last five years. Meanwhile, the employment of physician assistants is expected to grow 27 percent from 2006 to 2016 according to research by the U.S. Department of Labor Bureau of Labor Statistics. Most experts believe that the increases in these two professions have been prompted by the shortage of primary care physicians.

Despite their increasing importance in healthcare, Dr. Lacey says, "Neither group (NPs and PAs) is exposed to sleep medicine as part of their basic core curriculum, so I felt a course in sleep medicine would enhance their knowledge while improving overall patient care in their practices. I think some (NPs and PAs) may even choose to make sleep medicine their niche."

With this course and others, the Atlanta School has positioned itself as a leader in identifying and developing innovative educational courses for specialized populations. Gail Reid (http://www.sleepschool.com/bios.aspx?id=402), the program manager of the Atlanta Sleep School, says, "Although sleep medicine is not a recognized specialty for nurse practitioners and physician assistants, it certainly could be sometime in the near future. It is part of the Atlanta School of Sleep Medicine's mission to educate physicians as well as allied healthcare professionals in the practice of sleep disorders medicine and we believe that this course contributes significantly to this mission."

Teaching NPs and PAs more about the field of sleep medicine will benefit them and their practice by allowing them to treat more disorders knowledgably. Dr. Lacey says, "Training NPs and PAs makes them a more valuable asset to any primary care physicians practice, including subspecialties that commonly incorporate sleep medicine such as Neurology, Pulmonary, ENT, and Cardiology."

The Atlanta School of Sleep Medicine (http://www.sleepschool.com/Default.aspx) knows from experience that PAs and NPs are interested in learning about sleep medicine since they have frequently enrolled in the school's sleep medicine course for physicians (http://www.sleepschool.com/physician.aspx). Ludmilla R. Peller, a Nurse Practitioner in Minneapolis found the sleep course very beneficial, "I work in a sleep and pulmonary practice with 90% of my patients being seen for sleep issues. I do mostly follow up of CPAP, but also work with Insomnia, Restless Leg Syndrome and Narcolepsy patients. The (physician) class was very helpful as an overview for me, especially as I had no sleep background at that time. I still have my manual and refer to it often."

Patricia Benson, a Family Nurse Practitioner at a Sleep Disorders Center in Virginia said, "I see patients for initial evaluation and follow up of any sleep disorders. I attended the Atlanta Sleep School's physician program shortly after starting here (at the Sleep Disorders Center) and found it very helpful in getting up and running."

By taking this course, NPs and PAs will be exposed to a wide array of sleep disorders, including Obstructive Sleep Apnea, Insomnia, Restless Legs Syndrome, Parasomnias, Narcolepsy, and others. In the class, they will learn the causes, diagnosis, and treatment of all of these disorders. They will also learn the legal aspects of dealing with dangerously sleepy patients.

In the March issue of Sleep Review Magazine, Dr. Michael Lacey wrote more in depth about the increasing need for NPs and PAs in sleep medicine clinics in his guest editorial entitled, 'Making the Most of Nurse Practitioners and Physicians Assistants' (http://www.sleepreviewmag.com/issues/articles/2009-03_07.asp).

During the next few months, the Atlanta School of Sleep Medicine and Technology will host two sleep medicine dinner seminars for Nurse Practitioners and Physician Assistants in the Atlanta area. These programs will offer continuing education credit. Please call (678)651-2000 or email laura.baareman@sleepschool.com for more information.

About The Atlanta School of Sleep Medicine

Since 1992, the Atlanta School of Sleep Medicine & Technology in Atlanta has offered introductory and review courses for more than 5,000 physicians and health care professionals in sleep medicine and polysomnography. Four-day introductory courses are designed for physicians and 80-hour courses, which include an online component, are designed for technologists and allied health care professionals. The Atlanta School also offers special topics including board reviews, pediatric sleep, and business practices for sleep centers. For more information about the Atlanta School of Sleep Medicine, please visit the school's web site at www.sleepschool.com. Media Contact: Laura Baareman, laura.baareman@sleepschool.com, The Atlanta School of Sleep Medicine and Technology, (770)883-6679.

# # #



Contact Information Laura Baareman

The Atlanta School of Sleep Medicine and Technology

http://www.sleepschool.com

770-883-6679



TrainingPeaks Selected As "Official Training Software" Of Bike MS� And Joe Friel Selected As The "Official Coach"

TrainingPeaks Selected As "Official Training Software" Of Bike MS® And Joe Friel Selected As The "Official Coach"

Participants of the National Multiple Sclerosis Society's 100 Bike MS® fundraising events can now map, plan and train for their rides with Joe Friel and TrainingPeaks.com.

Lafayette, CO (PRWEB) July 7, 2009 - TrainingPeaks.com (www.trainingpeaks.com) has been selected as the "Official Training Software" of BikeMS®, the National MS Society's charity fundraising ride series (http://www.bikems.org/), which offers 100 unique events across the country annually. Bike MS participants can now map their rides, keep a food diary, workout log and track their heart rate, power, speed and much more either manually or by uploading exercise data from one of more than 80 popular training devices.

The National MS Society selected Joe Friel, endurance coach, author of the Cyclist's Training Bible and owner of the coaching company TrainingBible Coaching (http://www.trainingbible.com/) to be "Official Coach" of Bike MS. Friel developed a range of training plans for cyclists that are available on the TrainingPeaks software to provide Bike MS participants with the motivation and skills necessary to arrive well-prepared for their Bike MS experience, allowing them to finish their event eager to return for the following year.

"The support available through Training Peaks will ensure that all Bike MS participants have access to the training and tools they need to meet their own personal challenge and enjoy the ride - regardless of their level of experience," said Graham McReynolds, Executive Vice President of Marketing and Development at the Society. "Bike MS riders bring millions of dollars to the MS cause, so we want to honor their extraordinary efforts by providing the very best tools available to support their training and ride experience."

BikeMS event participants will have their choice of 6 cycling plans designed by Joe Friel for various route lengths -- from 50 miles to 150 miles, and ability levels -- from the beginner to the experienced rider. Participants will receive daily email workout reminders and they can track their progress as they move toward the day of the event in either a free Basic Personal Edition or in a Premium Personal Edition TrainingPeaks account for a monthly subscription fee.

"We are honored to have this opportunity to support Bike MS event participants with their extraordinary fundraising efforts as they pursue their vision of a world free of MS," said Donavon Guyot, CEO of Peaksware, the development company of TrainingPeaks. "By providing our TrainingPeaks software to each participant, we are helping all riders be a more effective part of the MS movement."

"TrainingBible Coaching is pleased to be working closely with the Bike MS program, revered as the largest organized cycling series in the country," said Joe Friel, founder of the coaching company. "As the Official Coaching Partner we are helping thousands of riders prepare for their challenges while they raise money for a great cause."

Cyclists currently registered for a Bike MS event will soon have access to both Joe Friel's training plans and to a TrainingPeaks account tailored for Bike MS and accessible directly from their BikeMS.org fundraising website.

About Peaksware:

Peaksware, LLC (http://peaksware.com/), founded in 1999, develops software systems to help motivated individuals and professionals achieve health, fitness and peak performance. In addition to the world's leading online training and nutrition log, TrainingPeaks.com, Peaksware also produces the desktop products Device Agent and WKO+. Each of these products is sold both direct to consumers and can also be customized in a white label format for enterprise customers. For more information or to discuss business development opportunities contact info_at_peaksware.com.

About TrainingBible Coaching:

TrainingBible Coaching applies the proven training methodologies and philosophies of its renowned books to client programs. The mission of TrainingBible Coaching is to provide coaching services to results-driven endurance athletes. This incorporates triathlon and cycling athletes from beginner to elite, both male and female.

To learn more about TrainingBible Coaching, please visit www.trainingbible.com.

About Bike MS:

Established in l980, the National MS Society's Bike MS® program is the largest organized cycling series in the country. Between March and October, l00 unique cycling events are offered by National MS Society chapters nationwide. Each ride in the Bike MS series offers distinct local flavor, while maintaining a well-organized, fully-supported, and exceptional overall experience. The Society offers fundraising and training assistance, as well as a consistently high level of safety and support on each ride. Bike MS brings people together as individuals and as teams to conquer a challenge and share an unforgettable experience with friends, family and coworkers, all while making a difference in the lives of people affected by MS. Visit www.bikems.org for additional information.

About the U.S. National Multiple Sclerosis Society:

MS stops people from moving. The National MS Society exists to make sure it doesn't. The Society addresses the challenges of each person affected by MS by funding cutting edge research, driving change through advocacy, facilitating professional education, collaborating with MS organizations around the world, and providing programs and services designed to help people with MS and their families move their lives forward. In 2008 alone, through its national office and 50 state network of chapters, it devoted over $136 million to programs that enhanced more than one million lives. To move us closer to a world free of MS, the Society also invested nearly $50 million to support 440 research projects around the world. To learn more about multiple sclerosis and the service programs the Society offers visit www.nationalMSsociety.org.

About Multiple Sclerosis:

Multiple sclerosis, an unpredictable, often disabling disease of the central nervous system, interrupts the flow of information within the brain, and between the brain and body. Every hour in the United States, someone is newly diagnosed with MS. Symptoms range from reduced or lost mobility to numbness and tingling to blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are moving us closer to a world free of MS. Most people with MS are diagnosed between the ages of 20 and 50, with at least two to three times more women than men being diagnosed with the disease. MS affects more than 400,000 people in the U.S., and 2.1 million worldwide.

###



Contact Information Elizabeth Hartman

Peaksware, LLC

http://www.trainingpeaks.com

303 532 1839

Jeremy Duerksen

Peaksware, LLC

http://peaksware.com



Thursday, July 2, 2009

The Brain Aneurysm Foundation Releases Early Detection Video to Educate First Responders to Symptoms of Brain Aneurysms

The Brain Aneurysm Foundation Releases Early Detection Video to Educate First Responders to Symptoms of Brain Aneurysms

The Brain Aneurysm Foundation has developed an educational video entitled Early Detection of Brain Aneurysms: Life vs. Death. Designed to educate primary care physicians, emergency room physicians and first responders on the early detection of brain aneurysms, this 20 minute video focuses on recognizing the symptoms related to a brain aneurysm and performing appropriate diagnostic brain imaging to determine if an aneurysm is present.

Boston, MA (PRWEB) July 2, 2009 -- An estimated one in fifty people in North America has a brain aneurysm. If the brain aneurysm is diagnosed early with proper screening, an aneurysm can be treated before it ruptures, saving lives. About 40% of those experiencing a ruptured brain aneurysm will die.

To help ensure the proper diagnosis of brain aneurysms, The Brain Aneurysm Foundation has developed an educational video entitled Early Detection of Brain Aneurysms: Life vs. Death. Designed to educate primary care physicians, emergency room physicians and first responders on the early detection of brain aneurysms, this 20 minute video focuses on recognizing the symptoms related to a brain aneurysm and performing appropriate diagnostic brain imaging to determine if an aneurysm is present. Early Detection of Brain Aneurysms: Life vs. Death is available now and can be viewed for CME credit at www.bafound.org or copies of the DVD can be acquired by calling 888-272-4602 or emailing office@bafound.org.

An estimated 6 million people in the United States have an unruptured brain aneurysm, a weak bulging spot on the wall of a brain artery. Individuals who receive treatment for an unruptured aneurysm generally require less rehabilitative therapy and recover more quickly than those that survive a ruptured aneurysm.

People who suffer a ruptured brain aneurysm (subarachnoid hemorrhage) will often have warning signs; however, they are often misdiagnosed. The most common warning signs are headaches, blurred vision, neck stiffness or pain, nausea or other neurological symptoms such as dizziness or numbness or a change in mental awareness. Misdiagnosis, or a delay in diagnosis of a ruptured brain aneurysm, may result in death or severe disability for the survivor.

With the help of the medical community, this early detection video can help promote brain aneurysm awareness and directly benefit those affected by brain aneurysms.

The video Early Detection of Brain Aneurysms: Life vs. Death has been planned and implemented in accordance with the Essentials Areas and Policies of the Accreditation Council for CME (ACCME) through the joint sponsorship of Vanderbilt School of Medicine and the Brain Aneurysm Foundation. Vanderbilt School of Medicine is accredited by the Accreditation Council for CME to provide Continuing Medical Education for physicians.

For more information on The Brain Aneurysm Foundation and Early Detection of Brain Aneurysms: Life vs. Death, please visit http://www.bafound.org.

About the Brain Aneurysm Foundation

The Brain Aneurysm Foundation was established in Boston, MA on August 19, 1994 as a public charity. The Brain Aneurysm Foundation is the nation's only nonprofit organization solely dedicated to providing critical awareness, education, support and research funding to reduce the incidence of brain aneurysms.

###



Contact Information ERIN CALLANAN

Brain Aneurysm Foundation

http://www.bafound.org

617-431-1171



Wednesday, July 1, 2009

International Collaboration led by Dr. Pablo V. Gejman,Researcher At NorthShore University HealthSystem’s Research Institute, Finds Genetic Association of Schizophrenia to Chromosome 6p Variant

International Collaboration led by Dr. Pablo V. Gejman,Researcher At NorthShore University HealthSystem’s Research Institute, Finds Genetic Association of Schizophrenia to Chromosome 6p Variant

The July 1, 2009 advance online edition of the journal Nature includes three companion papers describing the results of genome-wide association studies (GWAS) of schizophrenia. Schizophrenia is an elusive and severe psychiatric disorder that affects up to 70 million people worldwide. The causes of schizophrenia remain largely unknown and there is no cure, though for some individuals the current treatments work well. There are multiple factors that increase the risk for schizophrenia, of which genetic factors are the most prominent, though not precisely identified yet. This highlights the need for a better understanding of the pathways leading to schizophrenia to enable development of better treatments.

Evanston, IL (Vocus) July 1, 2009 -- The July 1, 2009 advance online edition of the journal Nature includes three companion papers describing the results of genome-wide association studies (http://www.genome.gov/20019523) (GWAS) of schizophrenia (http://www.nimh.nih.gov/health/topics/schizophrenia/index.shtml). Schizophrenia is an elusive and severe psychiatric disorder that affects up to 70 million people worldwide. The causes of schizophrenia remain largely unknown and there is no cure, though for some individuals the current treatments work well. There are multiple factors that increase the risk for schizophrenia, of which genetic factors are the most prominent, though not precisely identified yet. This highlights the need for a better understanding of the pathways leading to schizophrenia to enable development of better treatments.

Dr. Pablo Gejman, Director of the NorthShore University HealthSystem (NorthShore) Center for Psychiatric Genetics, led one of these three international collaborations, the Molecular Genetics of Schizophrenia (MGS). The MGS publication is entitled “Common variants on chromosome 6p22.1 are associated with schizophrenia.

Each study analyzed several thousand individuals with hundreds of thousands genetic markers distributed along the human genome, conducted the statistical analysis of their sample, and then shared data of their top results for a meta-analysis. The three samples combined comprised over 8,000 schizophrenia cases and over 19,000 control samples of European ancestry. “The combined analysis of the three datasets highlighted a region in chromosome 6p22.1 that is associated with schizophrenia," said Dr. Gejman.

The 6p22.1 region includes a histone (http://en.wikipedia.org/wiki/Histone) gene cluster (protein “spools” around which DNA wraps and affect the degree to which genes are turned on and off) and multiple immunity-related genes, suggesting a variety of possible pathophysiological mechanisms in schizophrenia, from abnormal transcriptional regulation to autoimmunity (http://www.nlm.nih.gov/medlineplus/autoimmunediseases.html) and maternal infections (http://www.nlm.nih.gov/medlineplus/viralinfections.html).

Dr. Gejman said, “These studies show that there are common variants increasing risk for schizophrenia, albeit representing small individual effects, and suggest that even larger samples may succeed in uncovering additional variants of pathophysiological importance, further illuminating the mechanisms of this devastating illness.”

Dr. Alan R. Sanders, a collaborator at NorthShore, states, “Schizophrenia is largely a genetic disease, though a complex one, and people who have close family members with schizophrenia are somewhat more likely to get this chronic, debilitating brain disorder. It usually begins in adolescence or early adulthood, and is characterized by hallucinations, delusions, disorganized thinking and behavior, and loss of interest and initiative. Chronic impairment in social functioning remains the more prevalent disease course, even with treatment.” Dr. Sanders further noted that, “Unlike the European ancestry only samples of the companion papers, the MGS sample also includes an African American (AA) subsample comprised by over 2,200 individuals. The AA GWAS results supported previously reported schizophrenia associations for the genes, ERBB4 on chromosome 2q34 and its ligand, neuregulin (NRG1 on chromosome 8p12).

The NorthShore team expects to continue to generate knowledge aimed at this goal of better therapeutics, such as more specific and effective medications with fewer side effects.

The studies were led, respectively, by Drs. Pablo V. Gejman of NorthShore University HealthSystem (MGS, the Molecular Genetics of Schizophrenia collaboration), Pamela Sklar of the Broad Institute (ISC, the International Schizophrenia Consortium), and Kari Stefansson of deCODE Genetics (SGENE, the Schizophrenia Gene consortium).

The MGS study was supported by the National Institute of Mental Health (multiple grants), the Paul Michael Donovan Charitable Foundation, NorthShore University HealthSystem the National Alliance for Research on Schizophrenia and Depression, the Genetic Association Information Network (GAIN, and the National Center for Research Resources

About NorthShore University HealthSystem

Located in Chicago's northern suburbs, NorthShore University HealthSystem (http://www.northshore.org/) (formerly Evanston Northwestern Healthcare) is an academic health system affiliated with the University of Chicago (http://www.uchicago.edu/)’s Pritzker School of Medicine. Our integrated delivery system includes Evanston (founded in 1891), Glenbrook, Highland Park, and Skokie Hospitals as well as the NorthShore Medical Group, Research Institute, and Foundation. NorthShore has annual revenues of $1.5 billion and a staff of more than 8,000. The fully integrated health system has significant capabilities in a wide spectrum of clinical programs, including cancer, heart, orthopedics, high-risk maternity, and pediatrics. NorthShore is a national leader in the implementation of innovative technologies, including electronic medical records.

CONTACT:

Rikki Ragland

Director, Public Relations

(847) 570-3144

rragland @ northshore.org

###



Contact Information Rikki Ragland

Northshore University Health System

http://www.northshore.org

847- 570-3144



Ziosoft Receives CE Marking Approval for Ziostation 3D Thin-Client Advanced Visualization System

Ziosoft Receives CE Marking Approval for Ziostation 3D Thin-Client Advanced Visualization System

Approval will allow Ziosoft to market its software solutions throughout Europe

Redwood City, CA (PRWEB) July 1, 2009 -- Ziosoft®, Inc. http://www.ziosoftinc.com a leader in advanced visualization and analysis software for medical imaging, today announced that it has received CE marking approval for its Ziostation 3D thin-client software system. CE marking approval allows Ziosoft to market its software solutions to the 27 countries in the European Union (EU) as well as the countries of the European Economic Area (EEA) which includes the countries of the European Free Trade Association (EFTA).

In anticipation of this approval, Ziosoft recently established a European headquarters in Brussels, Belgium and has formed a number of strategic alliances with partners and distributors throughout Europe. "CE marking approval is an important step in our strategy to broaden Ziosoft's position in the international market," said Bart Hendriks, Ziosoft's managing director for Europe, Middle East and Africa. "We believe Europe will be a significant area of growth for Ziosoft's thin-client advanced visualization software."

Ziosoft is the market leader in Japan since its founding there in 1998. In 2008 Ziosoft entered the U.S. market and has received a number of United States Food and Drug Administration (FDA) clearances for its software applications. Ziosoft is also in the process of registering the Ziostation system in Canada in line with the company strategy to provide global access to Ziosoft's innovative software solutions.

About Ziosoft Inc.

Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit physicians, patients, and healthcare specialists. Founded in 1998, Ziosoft is a leading independent advanced visualization company with over 1800 installed systems in over 800 sites worldwide. Ziosoft is dedicated to providing intelligent and intuitive clinical tools across the enterprise. Ziosoft is a privately held company with locations in Redwood City, CA, Brussels, Belgium, and Tokyo, Japan. For more information, please visit http://www.ziosoftinc.com.

Ziosoft and Ziostation are registered trademarks of Ziosoft Inc.

###



Contact Information Betsy Davis

Ziosoft

http://www.ziosoftinc.com

650-413-1374